The IMIM Erasmus Mundus is a two-year (120 ECTS) double-degree master’s program that prepares students for translational biomedical research and innovation. Spearheaded by four leading European institutions—University of Groningen, Heidelberg University (Mannheim Medical Campus), University of Tartu, and Uppsala University, it blends rigorous academic training with hands-on research, entrepreneurial mindset, and exposure to both academia and industry
Built around the unique “Bench to Bedside and Back” (BBB) multidisciplinary learning line, the program equips graduates with the skills to take innovations from the lab to real-world applications, culminating in strong career paths in academia, pharma, and entrepreneurship.
Project Status
- Status: Ongoing
- Start date 01-09-2024
- End date 31-10-2030
- Action Type: Erasmus Mundus Joint Master
- Universities Involved
- Countries Involved
The IMIM Erasmus Mundus program offers students the opportunity to study at four top-tier universities across Europe.
| University of Groningen |
| Heidelberg University |
| University of Tartu |
| Uppsala University |
| Estonia |
| Germany |
| Sweden |
| Netherlands |
This cross-border collaboration allows students to gain an international perspective while studying and researching in the heart of Europe’s academic and industrial hubs.
Description of the IMIM Erasmus Mundus Program
IMIM Erasmus Mundus is designed to cultivate “T-shaped” innovation leaders: those with deep biomedical expertise and broad skills in entrepreneurship, ethics, and soft skills. The interdisciplinary curriculum focuses on translational medicine, guiding students through fundamental research, critical thinking, and real-world application via the BBB project framework .
Key features of the IMIM Erasmus Mundus Program
- Double-degree: Earn two MSc diplomas from two partner institutions
- Mobility Mandates: Year‑1 in one institution, Year‑2 in another among the four universities
- BBB Learning Line: A continuous 16 ECTS innovation and entrepreneurship track
- Spring & Summer Schools: Skill development and industry exposure events
- Research Thesis: Semester four is dedicated to a research project at a university or partner.
- EIT Health and Erasmus+ labels: Recognized for excellence in innovation training
Mobility tracks of the IMIM Erasmus Mundus Program
Students follow one of several mobility tracks approved by the consortium. Four typical paths:
| Year 1 | Year 2 |
|---|---|
| UHEI | UG or UT or UU |
| UG | UT or UU |
| UT | UG or UU |
| UU | UG or UT |
Additionally, semester four can take place at a partner university in Latin America or in a private-sector institution.
Admission Requirements
Applicants should hold a bachelor’s degree (≈180 ECTS or equivalent) in fields such as biochemistry, molecular biology, biotechnology, medicine, dentistry, pharmaceutical or biomedical sciences. A strong academic track (GPA/excellence), research experience, and English proficiency (e.g., IELTS ≥ 6.5 or TOEFL IBT ≥ 92) are essential.
How to apply for the IMIM Erasmus Mundus Program
- Apply via the official IMIM portal (applications opened Nov 2024, deadline Jan 15, 2025)
- Upload required documents: transcripts, English test scores, CV, motivation letter, references, passport
- Choose preferences for first- and second-year universities
- Opt-in for an Erasmus+ EMJMD scholarship during application
Tips to win the IMIM Erasmus Mundus Program
- Showcase strong research experience and interdisciplinary curiosity in translational medicine
- Emphasize leadership roles, innovation, and entrepreneurial spirit (e.g., involvement in BBB-like projects)
- Tailor your motivation letter to match the IMIM mission, including mobility openness and cultural adaptability
- Secure outstanding referees who can attest to your academic and professional potential
- Prepare for interviews and ensure clarity and coherence in research plans
Application Timeline
| Event | Date |
|---|---|
| Application open | 1 Nov 2024 |
| Application deadline | 15 Jan 2025 (CET) |
| Selection results & interviews | Spring 2025 |
| Program start | 20 August 2025 |
Curriculum Structure of the IMIM Erasmus Mundus Program
- Year 1: Core courses and BBB modules + 30 ECTS research project
- Spring School (Heidelberg) developing soft skills & entrepreneurship
- Year 2: Advanced modules, BBB innovation modules, and Master’s thesis (30 ECTS)
- BBB Learning Line: 16 ECTS over four semesters
- Summer School (IPIM): Industry focus and pitch competition
Coordinator Contact
- For general inquiries, email: imim@rug.nl
Alumni Feedback
Students say:
“IMIM prepared me to bridge lab findings to real‑world applications and enter the life science industry confidently.”
Many graduates’ve gone on to PhDs, biotech companies, or started their own ventures.
Frequently Asked Questions (FAQs)
What scholarships are available for the IMIM Erasmus Mundus Program?
Full EMJMD scholarships cover tuition, travel, installation, and monthly allowances (€1,000–€1,400). Partial and self-funded spots are also available
What background is required for the IMIM Erasmus Mundus Program?
A bachelor’s in biomedical-related fields (biochemistry, molecular biology, biotech, medicine, dental), strong academic record, research experience, and English proficiency
Can non-EU students apply for the IMIM Erasmus Mundus Program?
Absolutely, IMIM is open globally. All admitted students (EU & non-EU) must pay fees unless awarded an EMJMD scholarship
How competitive is admission to the IMIM Erasmus Mundus Program?
Around 20–25 EMJMD scholarships awarded annually from over 600–1,300 applicants
What mobility options does the IMIM Erasmus Mundus Program offer?
Choose between four Europe-based mobility paths and optional research placements in Latin America or industry in the final semester
What career paths follow completion of the IMIM Erasmus Mundus Program?
Graduates pursue PhDs, roles in the biotech/pharma industry (research associates, project managers), or launch startups in biomedical innovation
